Dr. Barbara A. Wexelman, MD

Dr. Wexelman practices at TriHealth's Good Samaritan Hospital in Cincinnati, Ohio, part of TriHealth.

Dr. Wexelman's NPI, 1245542638, was assigned on July 14, 2010. Dr. Wexelman graduated from Yale University School of Medicine in 2008. Dr. Wexelman holds Ohio license 35-124307.

Dr. Wexelman's primary practice is TriHealth's Good Samaritan Hospital, at 375 Dixmyth Avenue, Cincinnati, OH 45220 in Hamilton County. The practice phone is (513) 862-2601.

Dr. Wexelman's primary practice is TriHealth's Good Samaritan Hospital in Cincinnati, Ohio, part of TriHealth. Dr. Wexelman is also affiliated with Bethesda North Hospital. The medical group on file is TriHealth. Dmand AI also links Dr. Wexelman to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wexelman practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Wexelman's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Wexelman is licensed in Ohio.

CMS data shows 217 Medicare services from Dr. Wexelman across 6 procedure codes in 2024, for 172 Medicare patients. Medicare paid $20,719 for them.

CMS counts 172 Medicare patients who saw Dr. Wexelman in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have cancer, and 72% have high cholesterol. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wexelman's median patient age at 67, with 98% women.

In 2024, Dr. Wexelman wrote 85 Medicare Part D claims for 67 patients. 100% of them were for generic drugs. CMS names the drug for 60 of them, across 3 drugs with 11 or more claims each, at $158 in total drug cost. In 2023, CMS named 58 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Wexelman for performance year 2024, reported through an alternative payment model (APM). Dr. Wexelman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of mastectomy by Dr. Wexelman, more than 88% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Wexelman, published from 2012 to 2024. 2013 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Mastectomy and Surgeons. Dr. Wexelman has published most often in Ann Surg Oncol. Dr. Wexelman's most frequent co-authors are Roshni Rao, MD, Oluwadamilola Motunrayo Fayanju, MD and Joshua P. Froman, MD.

CMS Open Payments shows 11 general payments to Dr. Wexelman from 8 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $144.

Dr. Wexelman graduated from Yale University School of Medicine in 2008.